Intended for healthcare professionals

Hidradenitis suppurativa – Part 2

Part one of this series covered the epidemiology, pathophysiology, risk factors, clinical features and investigations in hidradenitis suppurativa (HS). In the second part of this series, we will cover pharmacological treatment options for HS. Our final part of this three-part series will focus on dressings and surgical options.

Dermatology in practice 2022; 28(4): 84–86
To continue reading this article, please sign in or register.